|
|
News Breaks | | | | September 27, 2012 | | 04:55 EDT |  | TNXP, TNXP, TNXP, CUR, CUR, CUR, NVIV, NVIV, NVIV, APPY, APPY, APPY, PURE, PURE, PURE, GALE, GALE, GALE, CYTR, CYTR, CYTR, ROSG, ROSG, ROSG | Aegis to host a conference
2012 Aegis Healthcare Conference is being held in Las Vegas on September 27-29. | |
|
News For TNXP;CUR;NVIV;APPY;PURE;GALE;CYTR;ROSG From The Last 14 Days Check below for free stories on TNXP;CUR;NVIV;APPY;PURE;GALE;CYTR;ROSG the last two weeks. |
|
|
| May 15, 2013 | | 15:03 EDT |  | ROSG | Rosetta Genomics volatility elevated into ASCO
 Subscribe for More Information | | | May 10, 2013 | | 17:24 EDT |  | CUR | Neuralstem reports Q1 EPS (5c), consensus (5c)
Subscribe for More Information | | | 08:31 EDT |  | ROSG | Rosetta Genomics receives full settlement payment from Sanra
Subscribe for More Information | | | May 9, 2013 | | 17:32 EDT |  | APPY | Venaxis files to sell $23M of common stock
Subscribe for More Information | | | 16:23 EDT | | GALE | Galena Biopharma reports Q1 EPS (11c), consensus (7c)
Subscribe for More Information | | | 08:39 EDT | | CYTR | CytRx reports Q1 EPS (23c), consensus (15c)
Subscribe for More Information | | | 07:33 EDT | | GALE | Galena Biopharma's Abstral serves as model for TIRF REMS program
Subscribe for More Information | | | May 8, 2013 | | 08:35 EDT | | CYTR | CytRx to focus on clinical development of aldoxorubicin
Subscribe for More Information | | | May 6, 2013 | | 08:33 EDT | | CYTR | CytRx receives recommendation from DSMC to complete Phase 2b trial
Subscribe for More Information | |
|
|
|
|
|
|
